Beta-alethine

N/A

Report date: 2025/06/24 16:52:53
NME

Base Information

Drug NameBeta-alethine
Drug Alias NameAlethine betaβ-AlethineBetathineBeta LTAx-101
ClassificationSmall molecules
Mechanisms of ActionProgrammed cell death protein 1 inhibitors
TargetsProgrammed cell death protein 1
Therapy Area/IndicationsPrecancerous ConditionsPlasmacytomaMultiple Myeloma +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesThe University Of New Mexico
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLifetime Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsPrecancerous ConditionsPlasmacytomaMultiple Myeloma +[4] 

Other Information

ATC CodeN/A
Related LinksDrugBank